myHSteam

Sounds like you might be thinking of bimekizumab-bkzx (brand name Bimzelx)! It's a newer biologic that was FDA-approved for adults with moderate to severe HS.

What makes it different from other biologics is that it targets *both* IL-17A and IL-17F, which are key drivers of inflammation in HS. Here's what the clinical Show Full Answer

Sounds like you might be thinking of bimekizumab-bkzx (brand name Bimzelx)! It's a newer biologic that was FDA-approved for adults with moderate to severe HS.

What makes it different from other biologics is that it targets *both* IL-17A and IL-17F, which are key drivers of inflammation in HS. Here's what the clinical trials showed:

- Around 50% of participants saw at least a 50% reduction in HS symptoms after just 4 months
- Some people saw up to a 75% improvement in symptoms
- Benefits lasted through 48 weeks of the study

As with any medication, there are some things to be aware of. Common side effects include:

- Certain infections
- Fatigue
- Injection site reactions

It's always worth having a detailed conversation with your dermatologist to see if this could be a good fit for you, weighing both the potential benefits and risks.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Newly Approved Drug Reduces HS Symptoms by 50% in Trials